Company intelligence / Profile preview

Tillotts Pharma AG

Rheinfelden, Basel-Landschaft, Switzerlandtillotts.com ↗

Ownership: Private
Employees: ~400
Development stage: Preclinical

Overview

Tillotts Pharma AG has a strong commercial presence in gastrointestinal health, with several approved and marketed products for IBD, IBS, CDI, and related GI conditions. Their flagship product Asacol™ has over three decades of clinical use in ulcerative colitis. The company also markets Entocort™ for Crohn’s disease/microscopic colitis, Colpermin™ for IBS symptoms, VistaPrep™ for bowel cleansing before colonoscopy, and others. They have ongoing R&D focused on anti-inflammatory/anti-fibrotic targets in GI diseases.[6][7]

Therapeutic areas: GastroenterologyInfectious Diseases
Modalities: Small molecules[10]Chemical drugs[10]Antibodies (at least one program)[10]
Industry: Biotech

Drug pipeline

2 assets

TP05 Coating D

Unknown

1 more asset in the full pipeline.

Request access →

Partnerships

Partnerships with ABC Farmaceutici S.P.A.Augurix SA; historical licensing agreements with Medeva PLC/UCB; collaborations with University of Basel & University of Applied Sciences Northwest Switzerland on drug delivery technologies.[1]

Beyond the preview

Go deeper on Tillotts Pharma AG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tillotts Pharma AG.

Explore the full profile